Skip to content

Sleep, Pain and Quality of Life in Chronic Pain Patients

Sleep, Pain and Health-related Quality of Life in Chronic Pain Patients. Interventional Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04265586
Enrollment
554
Registered
2020-02-11
Start date
2020-08-14
Completion date
2023-12-31
Last updated
2024-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Insomnia

Keywords

Health-related Quality of Life, Anxiety, Pain intensity, Pain interference, Symptoms of insomnia

Brief summary

The interventional study will have two main aims. First, to compare two interventions aiming to improve sleep in chronic pain patients. And secondly, to study the associations of sleep, mood, chronic pain and quality of life. Half of participants will go through iCBT intervention for insomnia and the other half will receive sleep hygiene education. Additionally, the study will gather information which patients will benefit/will not benefit the tertiary pain clinic treatment when the outcome variable is the Health-related Quality of Life (HrQoL).

Detailed description

Sleep disturbances associates closely with chronic pain. It now seems that sleep problems usually precede and maintain persistent pain. Anxiety and worry frequently precede and associate with disturbed sleep and chronic pain. Depression is usually a consequence of chronic pain. Pain and depression disturb sleep further. These elements form a vicious circle where poor sleep is a critical driver. Previous studies have shown that sleep disturbances are a major contributor to the poor health-related quality of life (HRQoL) of patients with chronic pain.

Interventions

BEHAVIORALEducation

Sleep hygiene education is either face-to-face appointment or video-meeting with trained nurse.

BEHAVIORALWeb-based Cognitive Behavioural Therapy (iCBT)

iCBT is a web-based programme (7-16 weeks) designed to treat the symptoms of insomnia.

Sponsors

University of Helsinki
CollaboratorOTHER
Turku University Hospital
CollaboratorOTHER_GOV
Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* fluency in Finnish

Exclusion criteria

* severe psychiatric conditions (e.g. scizopherenia)

Design outcomes

Primary

MeasureTime frameDescription
Health-related Quality of Life (HrQoL) questionnaire (15D)Change from Baseline HrQoL at 12 months15-item questionnaire of HrQoL, ranging from 15 to 75 smaller value indicates better HrQoL

Secondary

MeasureTime frameDescription
Mood -BDI-II and STAI-YChange from Baseline mood at 12 monthsQuestionnaires about depression and anxiety, BDI-II values ranging from 0-63, and STAI-Y values ranging form 20-80 for both state and trait anxiety. Higher values in both questionnaires indicates higher amount of asked symptom.
Pain related catastrophizing (PCS)Change from Baseline pain related catatsrophizing at 12 monthsPain catastrophizing Scale, values ranging from 0 to 52, higher values indicating higher catasrophizing tendency.
Stress and worrying tendencyChange from Baseline stress and worrying tendency at 12 monthsQuestionnaires about perceived stress and worrying tendency. Values ranges from 16 to 80, higher values indicating higher amount of worring tendency.
Brief Pain Inventory (BPI)Change from Baseline pain intensity and interference at 12 months12-item questionnaire abour self-reported pain intensity and interference. Values ranges from 0 to 120, higher values indicating higher amount of pain interference and intensity.
Insomnia Severity Index (ISI)Change from Baseline symptoms of insomnia at 12 months5-item questionnaire of self-reported symptoms of insomnia. Values ranging from 0 to 28, higher values indicating higer amount of symptoms of insomnia.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026